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1. Introduction 
Much effort has been made to develop specific 
inhibitors of polyamine synthesis which may help in 
elucidating the role of polyamines in cellular metabo- 
lism and in cell proliferation in particular [l-7]. 
Furthermore, inhibitors of polyamine synthesis may 
find applications as antiproliferative agents. Four en- 
zymes are involved in the synthesis of polyamines in 
eukaryotic cells, i.e., ornithine decarboxylase, S-aden- 
osylmethionine(SAM) decarboxylase and two amino- 
propyltransferases, one catalyzing the synthesis of 
spermidine, the other producing spermine [8-121. 
Most inhibitory used are inhibitors of the two decar- 
boxylases, whereas several inhibitors are reported at 
the aminopropyltransferases [ 13-151. The relative 
activities of these enzymes must determine which of 
the polyamines accumulate in the cells. Marked dif- 
ferences in the spermidine to spermine ratio have 
been observed in comparisons of various mammalian 
cells [8,16] and spermidine levels are usually elevated 
in response to growth-promoting stimuli [8,16,17]. 
Here we demonstrate that partially purified spermidine 
synthase from rat ventral prostate was strongly inhib- 
ited by dicyclohexylamine and also by cyclohexyl- 
amine, and that administration of dicyclohexylamine 
caused a decrease in the concentration of spermidine 
but not spermine in the liver of partially hepatectom- 
ized rats. These inhibitors may be useful as experimen- 
tal tools for elucidating the physiological function of 
the polyamines. 
2. Materials and methods 
2.1. Chemicals 
Dicyclohexylamine sulfate(dicyclohexylammoni- 
Elsevier/Norlh-Holland Biomedical Press 
urn sulfate) was purchased from Sigma Chemical Co. 
Cyclohexylamine hydrochloride and aniline sulfate 
were products of Wako Pure Chemical Indust. S-Aden- 
osyl-L-[methyl-14C]methionine (spec. act. 50-60 
mCi/mmol) was obtained from New England Nuclear 
Corp. Decarboxylated SAM, both unlabeled and 
labeled in the methyl group was prepared by the action 
of SAM decarboxylase from Escherichia coli and 
purified by chromatography on Dowex-SO-H’and 
high-voltage paper electrophoresis [ 181. All other 
chemicals were products of Nakarai Chemicals Ltd. 
2.2. Animals 
Male Sprague-Dawley rats (160 g) were used for all 
experiments. Partial hepatectomy was performed 
under light ether anaesthesia s in [ 191. Dicyclohexyl- 
amine sulfate was dissolved in 0.14 M NaCl before 
administration and injected intraperitoneally at every 
24 h after partial hepatectomy (starting at the time of 
operation) until animals were sacrificed by decapi- 
tation. 
2.3. Preparation of spermidine and spennine synthases 
Spermidine and spermine synthases (aminopropyl- 
transferases) were purified from rat ventral prostate 
as in [20,21]. Extracts containing both enzyme activi- 
ties were fractionated into spermidine synthase and 
spermine synthase preparations by the treatment with 
ammonium sulfate followed by DEAE-cellulose and 
Ultrogel ACA 34 column chromatography. The en- 
zyme preparations used here were -250-fold (sper- 
midine synthase) and 160-fold (spermine synthase) of 
purification over the specific activity present in the 
crude ultracentrifugal extracts. 
2.4. Assay of aminopropyltransferase activities 
The aminopropyltransferase activity was deter- 
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mined by measuring the production of [met/~yZ-‘~C]- 
methylthioadenosine from decarboxylatedS-adenosyl- 
[methyl-14C]methi onine in the presence of putrescine 
(spermidine synthase) or of spermidme (spermine 
synthase) as in [ 121. The assay medium contained 
100 mM sodium phosphate buffer (pH 7.5), 5 mM 
dithiothreitol, 40 E.IM decarboxylated S-adenosyl- 
[methyl-r4C] methionine (2 j.&i/~mol), putrescine or 
spermidine (concentrations indicated in the legends) 
and the enzyme preparation in 0.2 ml total vol. Assays 
were incubated at 37°C for 30 min. The production 
of methylthioadenosine was entirely dependent on 
putrescine and spermidine. 
2.5. Detemination of polyamines 
The amounts of spermidine and spermine present 
in the liver were determined as in [22]; homogeni- 
zation of the tissue in 0.1 N HCl, extraction of amines 
into n-butanol at alkaline pH and separation by paper 
electrophoresis followed by staining with ninhydrin. 
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3. Results and discussion 
Fig.1 shows the dose-response curve for dicyclo- 
hexylamine on the inhibition of spermidine synthase 
and spermine synthase activities. Spermidine synthase 
was much more sensitive to the inhibitor than sper- 
mine synthase. The effect of the concentration of 
putrescine on the inhibition of spermidine synthase 
by dicyclohexylamine is shown in fig.2. This inhibition 
was competitive and the calculated Ki of dicyclo- 
hexylamine was 0.2 PM; Km for putrescine was 
29 PM. 
Removal of dicyclohexylamine from the active 
form of spermidine synthase by dialysis restored the 
activity to that found in preparations treated similarly 
except for exposure to the inhibitor. 
Dicyclohexylamine, when given to animals, was 
expected to lower the cellular spermidine level with- 
out affecting the spermine level. Fig.3 shows effects 
of administration of dicyclohexylamine on polyamme 
contents in the remnant livers of partially hepatec- 
Fig.2. Competitive inhibition of spermidine synthase by 
dicyclohexylamine with putrescine as the variable substrate. 
Spermidine synthase activity was assayed in the absence (0) 
or presence of 5 PM (0) or 10 NM (0) dicyclohexylamine, 
40 PM decarboxylated S-adenosylmethionine and 
0.0125-0.5 mM putrescine and an enzyme preparation. 
Fig.1. Inhibition of spermidine synthase and spermine synth- 
ase by dicyclohexylamine. The results are expressed as per- 
centages of the control activity measured in the absence of 
dicyclohexylamine. Putrescine and spermidine were 0.5 mM. 
Experimental details are given in the text. 
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Fig.3. Effect of administration of dicyclohexylamine on 
polyamine concentrations in the liver after partial hepatec- 
tomy. Groups of 3 rats were partially hepatectomized and 
injectedintraperitoneally with dicyclohexylamine (200 mg/kg) 
(9) or saline (0) every 24 h after partial hepatectomy (starting 
at the time of operation). Polyamine levels were determined 
as described in text. The upper two lines refer to spermidine, 
the lower two lines to spermine. 
tomized rats. A dose of 200 mg/kg caused a decrease 
in the concentration of spermidine with little effect 
on the spermine concentration, suggesting a decrease 
in spermidine synthase activity. 
As shown in table 1, spermidine synthase activity 
was inhibited also by cyclohexylamine to the same 
extent as by dicyclohexylamine. A cyclohexane ring 
Table 1 
A comparison of the inhibitory effect of dicyclohexylamine 
on spermidine synthase activity with those of related 
compounds 
Compound Concn. Inhibn. 
(mM) (%) 
Dicyclohexylamine 0.1 93.6 
Cyclohexylamine 0.1 88.7 
Aniline 0.1 2.7 
Tris-(hydroxymethyl)aminomethane 0.1 0.0 
Spermidine synthase activity was measured with the addition 
of the compound shown. The pH value of the reaction mix- 
ture was not changed by the addition of the compounds 
shown to the assay. Details of the experimental conditions 
were as described in the text 
having either a primary- or secondary-amino group 
might be essential for the inhibition of spermidine 
synthase activity. In this connection it is of interest 
that the benzene ring having an amino group had no 
inhibitory effect. 
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